tradingkey.logo
tradingkey.logo
Search

Niagen Bioscience Inc

NAGE
Add to Watchlist
3.480USD
+0.080+2.35%
Market hours ETQuotes delayed by 15 min
277.14MMarket Cap
14.90P/E TTM

NAGE Financials

See Niagen Bioscience Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Niagen Bioscience Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/0.02
Revenue / Forecast
--/30.69M
Period
FY2025 Earnings
Revenue(YoY)
129.42M
29.95%
EPS(YoY)
0.22
94.95%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
--0.08
--0.05
--0.06
--0.05
--0.07
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
3.26%31.47M
16.19%33.84M
32.86%33.99M
36.84%31.12M
37.59%30.48M
37.41%29.13M
31.21%25.58M
11.89%22.74M
-1.79%22.15M
0.95%21.20M
14.25%19.50M
21.46%20.32M
30.69%22.56M
18.23%21.00M
-1.42%17.06M
-5.46%16.73M
17.54%17.26M
14.98%17.76M
22.06%17.31M
15.78%17.70M
Net Profit
24.79%6.32M
-42.44%4.13M
143.77%4.58M
24160.00%3.61M
1129.07%5.06M
6197.37%7.18M
295.83%1.88M
99.32%-15.00K
74.13%-492.00K
108.04%114.00K
2.64%-959.00K
65.75%-2.19M
75.43%-1.90M
73.37%-1.42M
88.88%-985.00K
-14.93%-6.40M
-4.86%-7.74M
12.66%-5.33M
-110.11%-8.86M
-49.99%-5.57M
Net Margin
--20.07%
--12.21%
--13.47%
--11.60%
--16.61%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--63.47%
--64.14%
--64.52%
--65.00%
--63.42%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
--0.00%
--0.00%
--0.01%
--0.01%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
3.26%31.47M
16.19%33.84M
32.86%33.99M
36.84%31.12M
37.59%30.48M
37.41%29.13M
31.21%25.58M
11.89%22.74M
-1.79%22.15M
0.95%21.20M
14.25%19.50M
21.46%20.32M
30.69%22.56M
18.23%21.00M
-1.42%17.06M
-5.46%16.73M
17.54%17.26M
14.98%17.76M
22.06%17.31M
15.78%17.70M
Operating profit
-66.97%1.58M
-70.43%2.10M
164.42%4.24M
1344.14%3.19M
752.80%4.77M
4332.74%7.11M
239.67%1.60M
88.95%-256.00K
62.86%-731.00K
88.37%-168.00K
62.58%-1.15M
63.74%-2.32M
74.55%-1.97M
72.84%-1.44M
65.33%-3.06M
-15.00%-6.39M
-5.03%-7.73M
12.58%-5.32M
-110.70%-8.84M
-50.64%-5.55M
Net Profit
24.79%6.32M
-42.44%4.13M
143.77%4.58M
24160.00%3.61M
1129.07%5.06M
6197.37%7.18M
295.83%1.88M
99.32%-15.00K
74.13%-492.00K
108.04%114.00K
2.64%-959.00K
65.75%-2.19M
75.43%-1.90M
73.37%-1.42M
88.88%-985.00K
-14.93%-6.40M
-4.86%-7.74M
12.66%-5.33M
-110.11%-8.86M
-49.99%-5.57M
Current assets
37.92%105.12M
51.02%96.81M
79.57%93.62M
75.81%86.68M
55.62%76.22M
29.41%64.10M
10.50%52.13M
6.30%49.30M
5.18%48.98M
6.37%49.53M
24.48%47.18M
20.45%46.38M
4.59%46.56M
-4.78%46.57M
-28.27%37.90M
-33.53%38.51M
-29.57%44.52M
51.79%48.91M
71.94%52.84M
61.98%57.93M
Total current liabilities
9.54%22.82M
10.98%19.92M
28.32%22.71M
24.96%22.33M
7.12%20.84M
-12.97%17.95M
-8.97%17.70M
-6.26%17.87M
5.59%19.45M
15.41%20.62M
16.24%19.44M
7.54%19.06M
-1.45%18.42M
1.45%17.87M
-5.87%16.73M
9.22%17.73M
-5.38%18.69M
6.90%17.61M
36.53%17.77M
1.17%16.23M
Total assets
40.56%114.33M
55.84%106.41M
73.63%98.14M
69.38%91.53M
50.40%81.34M
24.22%68.28M
5.68%56.52M
1.62%54.03M
0.58%54.08M
1.68%54.96M
17.12%53.48M
14.07%53.17M
1.58%53.77M
-6.54%54.06M
-24.46%45.66M
-29.20%46.61M
-23.28%52.93M
50.79%57.84M
61.57%60.45M
56.80%65.84M
Total liabilities
23.11%32.00M
34.66%29.87M
23.97%27.46M
17.21%27.33M
3.44%25.99M
-16.31%22.18M
-15.37%22.15M
-10.39%23.32M
-2.42%25.13M
4.42%26.51M
6.22%26.18M
0.72%26.02M
-4.81%25.75M
-2.79%25.39M
-1.44%24.64M
9.01%25.84M
7.52%27.05M
19.05%26.11M
39.46%25.00M
16.11%23.70M
Total equity
48.76%82.33M
66.04%76.53M
105.64%70.68M
108.98%64.19M
91.17%55.34M
61.98%46.09M
25.86%34.37M
13.14%30.72M
3.33%28.95M
-0.75%28.46M
29.90%27.31M
30.67%27.15M
8.27%28.02M
-9.63%28.67M
-40.70%21.02M
-50.70%20.78M
-40.96%25.88M
93.17%31.73M
81.91%35.45M
95.27%42.14M
Net operating income
-115.15%-1.19M
-92.09%679.00K
5.64%3.69M
573.48%1.25M
2572.20%7.88M
1222.50%8.58M
782.58%3.50M
-108.05%-264.00K
-89.43%295.00K
297.87%649.00K
110.59%396.00K
185.59%3.28M
138.79%2.79M
93.37%-328.00K
36.81%-3.74M
51.46%-3.83M
-33.17%-7.20M
-22572.73%-4.94M
-53.94%-5.92M
-407.39%-7.89M
Net investment
16490.63%5.25M
-46.38%-101.00K
-14.29%-24.00K
-1025.00%-135.00K
21.95%-32.00K
-228.57%-69.00K
19.23%-21.00K
-140.00%-12.00K
54.95%-41.00K
87.79%-21.00K
50.00%-26.00K
94.12%-5.00K
-264.00%-91.00K
-8500.00%-172.00K
45.83%-52.00K
67.92%-85.00K
45.65%-25.00K
-112.50%-2.00K
-62.71%-96.00K
-159.80%-265.00K
Net financing
-173.75%-2.29M
-102.13%-80.00K
-85.76%148.00K
528.02%3.74M
22278.57%3.10M
5031.58%3.75M
34733.33%1.04M
6060.00%596.00K
-1300.00%-14.00K
-100.99%-76.00K
83.33%-3.00K
-150.00%-10.00K
66.67%-1.00K
12088.89%7.68M
-105.31%-18.00K
-100.18%-4.00K
-100.01%-3.00K
-94.67%63.00K
-31.10%339.00K
-67.62%2.25M

FAQs

What is the total revenue of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its total revenue reached 129.42M, with a year-on-year change of 99.60M.

What are the current assets of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its current assets were 96.81M, with a year-on-year change of 51.02.

What are the total assets of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its total assets of Niagen Bioscience Inc were 106.41M, with a year-on-year change of 55.84.

What are the total liabilities of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its total liabilities of Niagen Bioscience Inc were 29.87M, with a year-on-year change of 34.66.

What is the total equity of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its total equity of Niagen Bioscience Inc was 76.53M, with a year-on-year change of 66.04.

What is the net operating income of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its net operating income of Niagen Bioscience Inc was 14.30M, with a year-on-year change of 85.04.

What is the net investment of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its net investment of Niagen Bioscience Inc was -292.00K, with a year-on-year change of -104.20.

What is the net financing of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its net financing of Niagen Bioscience Inc was 6.92M, with a year-on-year change of 28.81.

What is the Earnings Per Share (EPS) of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.22, with a year-on-year change of 94.95.

What is the net income of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its net income was 17.38M, with a year-on-year change of 103.30.

What is the net margin of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its net profit margin was 13.43, with a year-on-year change of 56.45.

What is the gross margin of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its gross margin was 64.28, with a year-on-year change of 3.95.

What is the Return on Equity (ROE) of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its Return on Equity (ROE) was 28.35, with a year-on-year change of 23.59.

What is the Return on Assets (ROA) of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its Return on Assets (ROA) was 19.90, with a year-on-year change of 43.43.

What is the operating profit of Niagen Bioscience Inc?

According to Niagen Bioscience Inc's FY2025 earnings report, its operating profit was 14.30M, with a year-on-year change of 85.04.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.